Animal study · mice

PEG-MGF: heart function preserved after heart attack in mice

Checked against the paper Animal studyPublished by PepVault

The takeaway

This paper adds early cell and mouse evidence that the MGF E-domain peptide protected heart function and heart cells after a heart attack in mice, with no data in people yet.

Kind
Animal study
Studied in
Mice
Published
2013
Journal
Mol Cell Biochem

What they tested

The team wanted to learn what the E-domain region of mechano-growth factor (MGF) does in heart cells, and whether giving it could protect the heart after a heart attack.

How the study was done

A lab study that first tested a synthetic MGF E-domain peptide in H9c2 cells, then gave it to mice at the time of a myocardial infarction (heart attack). Treated mice were compared with untreated mice 2 weeks later.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking PEG-MGF? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

In H9c2 cells, the peptide was taken up quickly and moved to the cell nucleus without switching on the IGF-1 receptor. When the cells were stressed with sorbitol, the peptide blocked the intrinsic apoptosis pathway (a form of programmed cell death) by keeping the mitochondrial membrane potential from collapsing and stopping caspase-3 activation. In mice, untreated animals showed a significant drop in both systolic and diastolic heart function on PV loop analysis (pressure-volume measurements of the heart's pumping), while the peptide lessened that drop and significantly preserved contractility. Treated mice also had less pathologic hypertrophy (harmful thickening of heart muscle) and significantly fewer dying cell nuclei in the surviving heart muscle.

What it doesn’t show

Every result here comes from H9c2 cells and mice, so none of it has been shown in people. Mice were checked at only 2 weeks after the heart attack, and the substance given was a synthetic copy of the MGF E-domain region.

The paper

Mavrommatis et al. The E-domain region of mechano-growth factor inhibits cellular apoptosis and preserves cardiac function during myocardial infarction. Mol Cell Biochem. 2013.

The compound

More studies on PEG-MGF

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking PEG-MGF? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo